Novo Nordisk reported 64.01B in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Bausch Health Companies USD 1.77B 208M Jun/2025
Bristol-Myers Squibb USD 8.9B 714M Jun/2025
Eli Lilly USD 13.11B 2.61B Jun/2025
GlaxoSmithKline GBP 5.82B 229M Jun/2025
Merck USD 12.99B 224M Jun/2025
Novartis USD 11.51B 1.12B Jun/2025
Novo Nordisk 64.01B 1.19B Jun/2025
Novo Nordisk DKK 65.2B 5.19B Mar/2025
Pacira USD 125.91M 8.71M Jun/2025
Sanofi EUR 7.74B 26M Jun/2025
Supernus Pharmaceuticals USD 127.81M 6.25M Jun/2025